Search

everythinglearnresearchcommunity

for

Search:↓

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Neurohormones help control skin health and could treat skin disorders.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

The birth control pill with only progestogen can cause a false alarm in a hormone test.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments for hair loss are being developed using molecular biology.

A patch with curcumin-zinc can improve hair growth and health by delivering beneficial particles to the skin, increasing hair follicles, and reversing effects of a hair loss hormone.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.